Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification
Creator
Li, Hui
Wang, Chen
Dillon, Natalie
Wong, Freda Pui-Fan
Chan, Paul
Cheung, Albert
Fung, Yin-Wan
Lau,
Collins, Richard
Lin, Sau-Wah
Lok, Ting
Tam, Siu-Lun
Yu, -H
Yu, -Hoi
Source
Elsevier; Medline; PMC
abstract
Abstract An enhanced polymerase chain reaction (PCR) assay to detect the coronavirus associated with severe acute respiratory syndrome (SARS-CoV) was developed in which a target gene pre-amplification step preceded TaqMan real-time fluorescent PCR. Clinical samples were collected from 120 patients diagnosed as suspected or probable SARS cases and analyzed by conventional PCR followed by agarose gel electrophoresis, conventional TaqMan real-time PCR, and our enhanced TaqMan real-time PCR assays. An amplicon of the size expected from SARS-CoV was obtained from 28/120 samples using the enhanced real-time PCR method. Conventional PCR and real-time PCR alone identified fewer SARS-CoV positive cases. Results were confirmed by viral culture in 3/28 cases. The limit of detection of the enhanced real-time PCR method was 102-fold higher than the standard real-time PCR assay and 107-fold higher than conventional PCR methods. The increased sensitivity of the assay may help control the spread of the disease during future SARS outbreaks.
has issue date
2003-12-26
(
xsd:dateTime
)
bibo:doi
10.1016/j.bbrc.2003.11.064
bibo:pmid
14652014
has license
els-covid
sha1sum (hex)
f74923b3ce82c984a7ae3e0c2754c9e33c60554f
schema:url
https://doi.org/10.1016/j.bbrc.2003.11.064
resource representing a document's title
A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification
has PubMed Central identifier
PMC7111096
has PubMed identifier
14652014
schema:publication
Biochemical and Biophysical Research Communications
resource representing a document's body
covid:f74923b3ce82c984a7ae3e0c2754c9e33c60554f#body_text
is
schema:about
of
named entity 'The limit'
named entity 'viral culture'
named entity 'The'
named entity 'assay'
named entity 'PRE'
named entity 'PROBABLE'
named entity 'DIAGNOSED'
named entity 'OBTAINED'
named entity 'INCREASED SENSITIVITY'
named entity 'USING'
named entity 'ANALYZED'
named entity 'AGAROSE GEL ELECTROPHORESIS'
named entity 'POLYMERASE CHAIN REACTION'
named entity 'PATIENTS'
named entity 'REAL-TIME'
named entity 'SEVERE ACUTE RESPIRATORY SYNDROME'
named entity 'FOLD'
named entity 'TARGET GENE'
named entity 'FOLLOWED BY'
named entity 'ENHANCED'
named entity 'LIMIT OF DETECTION'
covid:arg/f74923b3ce82c984a7ae3e0c2754c9e33c60554f
named entity 'SUSPECTED'
named entity 'TAQMAN'
named entity 'DISEASE'
named entity 'CORONAVIRUS'
named entity 'STANDARD'
named entity 'SAMPLES'
named entity 'OUR'
named entity 'METHODS'
named entity 'SIZE'
named entity 'FLUORESCENT'
named entity 'PCR'
named entity 'SARS-COV'
named entity 'CONVENTIONAL'
named entity 'REAL-TIME PCR'
named entity 'ASSAY'
named entity 'AMPLICON'
named entity 'COLLECTED'
named entity 'OUTBREAKS'
named entity 'SPREAD'
named entity 'REAL-TIME PCR '
named entity 'IDENTIFIED'
named entity 'EXPECTED'
named entity 'CLINICAL'
named entity 'POSITIVE'
named entity 'AMPLIFICATION'
named entity 'RESULTS'
named entity 'CASES'
named entity 'FUTURE'
named entity 'CONFIRMED BY'
named entity 'STEP'
named entity 'ASSOCIATED WITH'
named entity 'VIRAL CULTURE'
named entity 'PRECEDED'
named entity '120'
named entity 'SARS'
named entity 'CONTROL'
named entity 'HELP'
named entity 'TO DETECT'
named entity 'HIGHER'
named entity 'agarose gel electrophoresis'
named entity 'SARS-CoV'
named entity 'fluorescent'
named entity 'detection'
named entity 'Applied Biosystems'
named entity 'clinical data'
named entity 'SARS'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 6
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software